Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Amedisys, Inc. stock logo
AMED
Amedisys
$92.08
-0.4%
$92.36
$73.10
$96.44
$3.01B0.84208,427 shs246,626 shs
CDI Corp stock logo
CDI
CDI
$8.22
$0.00
$4.84
$9.65
N/AN/A81,650 shsN/A
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Amedisys, Inc. stock logo
AMED
Amedisys
-0.38%+0.32%-0.58%-2.74%+17.11%
CDI Corp stock logo
CDI
CDI
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Amedisys, Inc. stock logo
AMED
Amedisys
2.7695 of 5 stars
1.12.00.05.02.61.71.3
CDI Corp stock logo
CDI
CDI
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Amedisys, Inc. stock logo
AMED
Amedisys
2.13
Hold$97.505.89% Upside
CDI Corp stock logo
CDI
CDI
N/AN/AN/AN/A

Current Analyst Ratings

Latest FRCL, DP3D, AMED, and CDI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/25/2024
Amedisys, Inc. stock logo
AMED
Amedisys
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$101.00
3/26/2024
Amedisys, Inc. stock logo
AMED
Amedisys
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform ➝ Market Perform
3/25/2024
Amedisys, Inc. stock logo
AMED
Amedisys
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$97.00 ➝ $100.00
(Data available from 5/4/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Amedisys, Inc. stock logo
AMED
Amedisys
$2.24B1.35$6.09 per share15.12$34.97 per share2.63
CDI Corp stock logo
CDI
CDI
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Amedisys, Inc. stock logo
AMED
Amedisys
-$9.75M-$0.64N/A18.493.44-0.91%12.85%6.95%7/24/2024 (Estimated)
CDI Corp stock logo
CDI
CDI
N/AN/A0.00N/AN/AN/AN/AN/A

Latest FRCL, DP3D, AMED, and CDI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/24/2024Q1 2024
Amedisys, Inc. stock logo
AMED
Amedisys
$1.02$1.03+$0.01$1.62$565.38 million$571.41 million  
2/21/2024Q4 2023
Amedisys, Inc. stock logo
AMED
Amedisys
$1.04$0.94-$0.10$1.29$566.85 million$570.79 million  

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Amedisys, Inc. stock logo
AMED
Amedisys
N/AN/AN/AN/AN/A
CDI Corp stock logo
CDI
CDI
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Amedisys, Inc. stock logo
AMED
Amedisys
0.31
1.09
1.09
CDI Corp stock logo
CDI
CDI
N/AN/AN/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Amedisys, Inc. stock logo
AMED
Amedisys
94.36%
CDI Corp stock logo
CDI
CDI
35.88%

Insider Ownership

CompanyInsider Ownership
Amedisys, Inc. stock logo
AMED
Amedisys
1.80%
CDI Corp stock logo
CDI
CDI
8.80%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Amedisys, Inc. stock logo
AMED
Amedisys
19,00032.68 million32.09 millionOptionable
CDI Corp stock logo
CDI
CDI
N/AN/AN/ANot Optionable

DP3D, AMED, CDI, and DP2D Headlines

SourceHeadline
Bettors Lose Case Against Baffert, CDI in Appeals CourtBettors Lose Case Against Baffert, CDI in Appeals Court
bloodhorse.com - May 3 at 1:01 PM
Susceptibility of Superbug Clostridioides difficile to Vancomycin is DecreasingSusceptibility of Superbug Clostridioides difficile to Vancomycin is Decreasing
emjreviews.com - May 3 at 8:00 AM
Kentucky Derby notes: Jayson Werth’s horse is in. Bob Baffert’s is out.Kentucky Derby notes: Jayson Werth’s horse is in. Bob Baffert’s is out.
msn.com - May 2 at 1:29 PM
Horse racing is looking to move on from Bob Baffert-Churchill Downs feudHorse racing is looking to move on from Bob Baffert-Churchill Downs feud
msn.com - May 2 at 1:29 PM
Why is the Block share price diving 5% the day before results?Why is the Block share price diving 5% the day before results?
msn.com - May 2 at 3:28 AM
Horse racing’s household name will miss third straight Kentucky DerbyHorse racing’s household name will miss third straight Kentucky Derby
pennlive.com - May 1 at 5:27 PM
NexGen Energy upsizes CDI offering to C$224mNexGen Energy upsizes CDI offering to C$224m
mining-technology.com - May 1 at 12:27 PM
2024 Beta 300 RR Race Edition Technical Information2024 Beta 300 RR Race Edition Technical Information
msn.com - May 1 at 7:27 AM
13 RWD Cars With Bulletproof Engines Thatll Last 500,000 Miles13 RWD Cars With Bulletproof Engines That'll Last 500,000 Miles
msn.com - May 1 at 2:26 AM
Watch This 1998 Honda 300EX Quad Come Back To Life After Sitting For YearsWatch This 1998 Honda 300EX Quad Come Back To Life After Sitting For Years
msn.com - April 30 at 9:25 PM
FCED Executive Director Beth Bilyeu receives NIACC Distinguished Alumna AwardFCED Executive Director Beth Bilyeu receives NIACC Distinguished Alumna Award
globegazette.com - April 30 at 9:25 PM
BC Partners leveraged increased demand for increasingly complex IT services to grow PresidioBC Partners leveraged increased demand for increasingly complex IT services to grow Presidio
pehub.com - April 30 at 9:25 PM
Kentucky Derby ‘Unique’ Asset With Added Focus On Milestone, BettingKentucky Derby ‘Unique’ Asset With Added Focus On Milestone, Betting
legalsportsreport.com - April 30 at 9:25 PM
Bob Baffert to miss 3rd consecutive Kentucky DerbyBob Baffert to miss 3rd consecutive Kentucky Derby
journalgazette.net - April 29 at 7:26 PM
Dancing Into Oblivion—Why Did Foxtrot Fail?Dancing Into Oblivion—Why Did Foxtrot Fail?
cspdailynews.com - April 29 at 7:26 PM
Bob Baffert will miss his third straight Kentucky DerbyBob Baffert will miss his third straight Kentucky Derby
pressherald.com - April 29 at 7:26 PM
Horse racings household name will miss the 150th Kentucky DerbyHorse racing's household name will miss the 150th Kentucky Derby
voanews.com - April 29 at 7:26 PM
Horse racings household name will miss the 150th Kentucky Derby. Bob Baffert is exiled for 3rd yearHorse racing's household name will miss the 150th Kentucky Derby. Bob Baffert is exiled for 3rd year
abcnews.go.com - April 29 at 2:26 PM
5 Most Powerful Turbocharged Motorcycles Of All Time5 Most Powerful Turbocharged Motorcycles Of All Time
topspeed.com - April 28 at 7:25 PM
Joseph Returns to KY Derby After CDIs 23 SuspensionJoseph Returns to KY Derby After CDI's '23 Suspension
bloodhorse.com - April 27 at 6:58 PM
CDI student summitCDI student summit
thecrite.com - April 26 at 9:41 PM
Judge denies request for Bob Baffert-trained Muth to run in Kentucky Derby 2024Judge denies request for Bob Baffert-trained Muth to run in Kentucky Derby 2024
msn.com - April 26 at 4:40 PM
Kentucky Derby’s Purse, Betting Reaches All-Time HighKentucky Derby’s Purse, Betting Reaches All-Time High
sportscasting.com - April 26 at 4:40 PM
Bob Bafferts Horse Muth Wont Run in 2024 Kentucky Derby After Losing AppealBob Baffert's Horse Muth Won't Run in 2024 Kentucky Derby After Losing Appeal
bleacherreport.com - April 26 at 4:40 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Amedisys logo

Amedisys

NASDAQ:AMED
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.
CDI logo

CDI

NYSE:CDI
CDI Corp. provides engineering, information technology and staffing solutions. The Company operates in three segments: Global Engineering and Technology Solutions (GETS), Professional Staffing Services (PSS) and Management Recruiters International (MRI). It provides staffing services through its MRINetwork of franchisees. The GETS segment provides engineering and information technology solutions that involve the production of deliverable work products or services performed at its facility or at a customer's facility. The PSS segment provides technical and professional personnel for discrete periods of time to augment the customer's workforce in times of project, seasonal, peak period or business cycle needs. The MRI segment is a global franchisor that does business as MRINetwork and provides the use of its trademarks, business systems and training and support services to its franchisees. It serves the oil, gas and chemicals, aerospace and industrial equipment, and hi-tech industries.